StockData
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$21.14+0.10 (+0.48%)

Close on Nov 13, 2026Market cap $413.27MP/E –Yield 0.00%

Tectonic Therapeutic price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tectonic Therapeutic's price to book ratio was 1.9× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 0.1× to 5.3×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×+0.4
2025Dec 31, 20251.5×−3.1
2024Dec 31, 20244.5×+4.4
2023Jan 31, 20230.1×+0.0
2022Dec 30, 20220.1×−0.2
2021Dec 31, 20210.3×−0.5
2020Dec 31, 20200.8×−0.2
2019Dec 31, 20191.0×+0.1
2018Dec 31, 20180.9×–

More Tectonic Therapeutic figures

See a number that looks wrong?